Evidence map›Paper›PMID 23243208›Full record

ArticleCirculation research2013

β-Adrenergic regulation of cardiac progenitor cell death versus survival and proliferation.

Mohsin Khan, Sadia Mohsin, Daniele Avitabile, Sailay Siddiqi, Jonathan Nguyen, Kathleen Wallach, Pearl Quijada, Michael McGregor, Natalie Gude, Roberto Alvarez and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Circulation research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 65 citations in OpenAlex.

  1. Cardiac Progenitor Cell Metabolism.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Cardiac Progenitor Cells: The Matrix Has You.Stem cells translational medicine · 2018
    Article
  9. Modulation of cardiac stem cell characteristics by metoprolol in hypertensive heart disease.Hypertension research : official journal of the Japanese Society of Hypertension · 2018
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Stimulating endogenous cardiac repair.Frontiers in cell and developmental biology · 2015
    Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Mohsin KhanSan Diego Heart Research Institute, San Diego State University, San Diego, CA 92182, USA.
Sadia Mohsin
Daniele Avitabile
Sailay Siddiqi
Jonathan Nguyen
Kathleen Wallach
Pearl Quijada
Michael McGregor
Natalie Gude
Roberto Alvarez
Douglas G Tilley
Walter J Koch
Mark A Sussman
San Diego State University · US

Funding

Surgery, Physiology and ImmunohistopathologyP01HL085577 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI GUSTAFSSON, ASA B. · 2006 to 2017
$18.4M
Regulation of Signal Transduction to Treat Heart FailureR01HL067245 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN · 2001 to 2021
$6.0M
Stem Cell Signaling in the Pathologically Challenged MyocardiumR37HL091102 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN · 2008 to 2017
$3.8M
Molecular Mechanisms of Cardiac beta1AR-EGFR Association and SignalingR01HL105414 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI TILLEY, DOUGLAS · 2011 to 2019
$3.4M
GRK and b-Arrestin Signaling in Cardiac RegenerationR01HL085503 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI KOCH, WALTER J. · 2007 to 2015
$3.0M
Beta-adrenergic signaling: double edged sword of myocardial repairR01HL117163 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN · 2013 to 2017
$1.9M
Antagonism of myocardial aging and senescence with Pim-1 kinaseR01HL105759 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN · 2011 to 2015
$1.8M
Cardioprotection by optimizing mTOR activityR01HL113647 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN · 2013 to 2016
$1.5M
Engineering Cardiac Progenitor Cells to Enhance Myrocardial RegengerationRC1HL100891 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN, WU, JOSEPH C. · 2009 to 2010
$1.0M
Molecular Engineering of Damaged Myocardium To Enhance Regeneration And RepairR01HL113656 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN · 2012 to 2013
$667k
Nucleolar disruption in response to cardiomyopathic stress and injuryR21HL102714 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN · 2010 to 2011
$411k
Inducible Notch improves progenitor cell repair of damaged heartR21HL104544 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN · 2010 to 2011
$411k
NHLBI NIH HHS P01 HL085577NHLBI NIH HHS P01HL085577NHLBI NIH HHS R01 HL067245NHLBI NIH HHS R01HL067245NHLBI NIH HHS R01 HL085503NHLBI NIH HHS R01 HL105414NHLBI NIH HHS R01 HL105759NHLBI NIH HHS R01HL105759NHLBI NIH HHS R01 HL113647NHLBI NIH HHS R01 HL113656NHLBI NIH HHS R01 HL117163NHLBI NIH HHS R21 HL102613NHLBI NIH HHS R21HL102613NHLBI NIH HHS R21 HL102714NHLBI NIH HHS R21HL102714NHLBI NIH HHS R21 HL104544NHLBI NIH HHS R37 HL091102NHLBI NIH HHS R37HL091102NHLBI NIH HHS RC1 HL100891NHLBI NIH HHS RC1HL100891
6 · The paper itself

Abstract

rationaleShort-term β-adrenergic stimulation promotes contractility in response to stress but is ultimately detrimental in the failing heart because of accrual of cardiomyocyte death. Endogenous cardiac progenitor cell (CPC) activation may partially offset cardiomyocyte losses, but consequences of long-term β-adrenergic drive on CPC survival and proliferation are unknown.

objectiveWe sought to determine the relationship between β-adrenergic activity and regulation of CPC function. METHODS AND

resultsMouse and human CPCs express only β2 adrenergic receptor (β2-AR) in conjunction with stem cell marker c-kit. Activation of β2-AR signaling promotes proliferation associated with increased AKT, extracellular signal-regulated kinase 1/2, and endothelial NO synthase phosphorylation, upregulation of cyclin D1, and decreased levels of G protein-coupled receptor kinase 2. Conversely, silencing of β2-AR expression or treatment with β2-antagonist ICI 118, 551 impairs CPC proliferation and survival. β1-AR expression in CPC is induced by differentiation stimuli, sensitizing CPC to isoproterenol-induced cell death that is abrogated by metoprolol. Efficacy of β1-AR blockade by metoprolol to increase CPC survival and proliferation was confirmed in vivo by adoptive transfer of CPC into failing mouse myocardium.

conclusionsβ-adrenergic stimulation promotes expansion and survival of CPCs through β2-AR, but acquisition of β1-AR on commitment to the myocyte lineage results in loss of CPCs and early myocyte precursors.

Indexed as

Cell ProliferationSignal TransductionAdrenergic beta-2 Receptor AgonistsAdrenergic beta-2 Receptor AntagonistsAnimalsCell DeathCells, CulturedCell SurvivalCoculture TechniquesCyclin D1Disease Models, AnimalDose-Response Relationship, DrugG-Protein-Coupled Receptor Kinase 2HumansMaleMiceADRB2 protein, humanAdrenergic beta-2 Receptor AgonistsAdrenergic beta-2 Receptor AntagonistsCCND1 protein, humanCcnd1 protein, mouseCyclin D1G-Protein-Coupled Receptor Kinase 2GRK2 protein, humanGRK2 protein, mouseMAPK1 protein, humanMapk1 protein, mouseMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Nitric Oxide Synthase Type IIINOS3 protein, humanNos3 protein, mouseProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-kitReceptors, Adrenergic, beta-1Receptors, Adrenergic, beta-2

Identifiers

PMID23243208
PMCPMC3595054
OpenAlexW2170297351

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.